Identification of KRASG12C Mutations in Circulating Tumor DNA in Patients With Cancer

循环肿瘤DNA 癌症 克拉斯 DNA 癌症研究 鉴定(生物学) 分子生物学 医学 内科学 肿瘤科 生物 遗传学 结直肠癌 植物
作者
Kyaw Zin Thein,Amadeo B. Biter,Kimberly C. Banks,Andrew W. Duda,Jennifer Saam,Jason Roszik,Filip Jankú,Ferdinandos Skoulidis,John V. Heymach,Scott Kopetz,Funda Meric‐Bernstam,David S. Hong
出处
期刊:JCO precision oncology [Lippincott Williams & Wilkins]
卷期号: (6) 被引量:13
标识
DOI:10.1200/po.21.00547
摘要

PURPOSE KRAS is the most mutated proto-oncogene that has been identified in cancer, and treatment of patients with KRAS mutations remains an arduous challenge. Recently, KRAS G12C mutation has attracted special interest because it is now considered potentially druggable with recently developed covalent small-molecule KRAS G12C inhibitors. Nevertheless, to date, there have been no large-scale analyses of liquid biopsy that include testing for KRAS G12C . Here, we performed a comprehensive analysis of KRAS G12C mutations in multiple cancer types, as detected by circulating tumor DNA. METHODS We conducted a 5-year retrospective review of KRAS G12C mutations in patients with cancer who had undergone Guardant360 testing between July 1, 2014, and June 30, 2019; our study included treatment-naive and previously treated patients with metastatic solid tumors. RESULTS KRAS G12C mutations were identified in 2,985 of 80,911 patients (3.7%), across > 40 tumor types. KRAS G12C mutations were detected most frequently in patients with nonsquamous non–small-cell lung cancer (NSCLC; 7.5%), NSCLC of all subtypes (6.9%), cancer of unknown primary (4.1%), colorectal cancer (3.5%), squamous NSCLC (2.0%), pulmonary neuroendocrine tumors (1.9%), and pancreatic ductal adenocarcinoma (1.2%) and cholangiocarcinoma (1.2%). KRAS G12C mutations were predominantly clonal (clonality > 0.9%) in patients with lung adenocarcinoma, non-NSCLC, cancer of unknown primary, NSCLC, and pancreatic ductal adenocarcinoma, and patients with colorectal cancer and breast cancer had bimodal distribution of clonal and subclonal KRAS G12C mutations. CONCLUSION Our study demonstrates the feasibility of using circulating tumor DNA to identify KRAS G12C mutations across solid tumors; the highest detection rate was in lung cancer, as previously reported in the literature.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yuanjingnan完成签到,获得积分10
刚刚
QAQ发布了新的文献求助10
1秒前
花花完成签到,获得积分10
1秒前
Dan发布了新的文献求助10
1秒前
chunfengfusu发布了新的文献求助10
1秒前
程伊森发布了新的文献求助10
2秒前
aaa完成签到,获得积分10
2秒前
2秒前
xz完成签到 ,获得积分10
4秒前
4秒前
1618发布了新的文献求助10
4秒前
5秒前
搜集达人的应助被xtc采纳,获得10
6秒前
zorro3574完成签到,获得积分10
9秒前
9秒前
踏实的盼柳的应助被WaNgBO采纳,获得10
9秒前
9秒前
10秒前
BANANA发布了新的文献求助10
10秒前
王乐安完成签到,获得积分10
10秒前
Able完成签到 ,获得积分10
11秒前
时尚篮球完成签到,获得积分10
11秒前
11秒前
赘婿的应助被we采纳,获得10
13秒前
行者发布了新的文献求助10
13秒前
kkm发布了新的文献求助10
14秒前
14秒前
韶枫完成签到,获得积分10
14秒前
滴滴答答发布了新的文献求助10
14秒前
kakak完成签到,获得积分10
15秒前
哈哈哈完成签到 ,获得积分10
15秒前
落幕无悔完成签到 ,获得积分10
15秒前
蜜雪冰城完成签到,获得积分10
16秒前
乌黑的眼圈完成签到,获得积分10
16秒前
16秒前
xtc发布了新的文献求助10
17秒前
18秒前
18秒前
YanChengHan完成签到,获得积分10
19秒前
在水一方的应助被陆羽泡的茶采纳,获得10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158017
求助须知:如何正确求助?哪些是违规求助? 9553900
关于积分的说明 21716555
捐赠科研通 7747340
什么是DOI,文献DOI怎么找? 3426934
关于科研通互助平台的介绍 2551639
邀请新用户注册赠送积分活动 2471005